Hopefully you've sold already and don't have to worry about the price. I guess Roth Capital found some suckers to put in $1.5 million even thought it's going to zero.
The other way to look at it is they are now capitalized for another 7 months to get through their January FDA meeting and to develop their IP so they'll be able to raise more money at a better price down the road.
This could go to zero if they don't execute but clearly they have better IP than any other cannabis pharmaceutical companies.
News 
Market Data 
Discover 
